News Releases | Lucira Health, Inc

Year

11 Aug '22

Lucira Announces Health Canada Authorization of First and Only 99% Accurate At-Home Covid & Flu Test

EMERYVILLE, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tests, today announced that Health

02 Aug '22

Lucira Health to Announce Second Quarter 2022 Financial Results

EMERYVILLE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will report second

01 Aug '22

Lucira Health Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

EMERYVILLE, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of innovative infectious disease tests today announced that on July 27, 2022, the Board of Directors

04 Jul '22

Lucira Health’s At-Home COVID-19 Test Granted Full Exemption by New Zealand Ministry of Health

New Zealanders can now get fast, accurate COVID-19 test results without leaving home and unnecessarily exposing themselves or others to the virus. The Lucira COVID-19 molecular test: • Displays a positive result in as little as 11 minutes, negative in 30 minutes • Provides 98% accuracy as compared

12 May '22

Lucira Health Announces First Quarter 2022 Results and Business Update

EMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) (“Lucira Health,” “Lucira” or the “Company”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tests, today reported financial

12 May '22

Lucira Files for Authorization of First-of-its-Kind COVID-19 & Flu At-Home Molecular Test

This first ever at-home COVID-19 and flu test is designed to allow individuals to differentiate between the infections and seek appropriate treatment within 30 minutes from home EMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a

09 May '22

Lucira Receives CE Mark for both COVID-19 & Flu and COVID-19 Molecular Tests

EMERYVILLE, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of innovative infectious disease tests, announced that both its COVID-19 & Flu and COVID-19 molecular

04 May '22

Lucira Health to Participate in Bank of America 2022 Healthcare Conference

EMERYVILLE, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will participate in

28 Apr '22

Lucira Health to Announce First Quarter 2022 Financial Results

EMERYVILLE, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will report first

21 Apr '22

Lucira Health and USA Boxing Announce Exclusive Partnership for the 2022 Season

Lucira is the official COVID-19 test provider of USA Boxing athletes and staff and will commit $5 of support to the organization for each test purchased by fans Emeryville, Calif., April 21, 2022 -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 20